Biotech | August 08, 2021
TAKE divests stake in Navitas Life Sciences to HIG
The transaction is expected to close in the Q4FY22
The transaction is expected to close in the Q4FY22
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Advances deployment of mRNA technology across vaccines and therapeutics development
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
AstraZeneca, Sinopharm and Moderna were part of the study
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
The company has been consistently reducing debt
Subscribe To Our Newsletter & Stay Updated
